Akero Therapeutics Inc (AKRO)

06:26 AM

Readystate Asset Management LP Invests $4.07 Million in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

06:26 AM

04:29 AM

Jennison Associates LLC Takes Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

04:29 AM

03:03 AM

Akero Therapeutics Inc. Stock Analysis and ForecastFastest-growing stock picks - Autocar Professional

03:03 AM

03:01 AM

Is Akero Therapeutics Inc. a good long term investmentHigh-velocity gains - Autocar Professional

03:01 AM

02:57 AM

What drives Akero Therapeutics Inc. stock priceExponential wealth increase - Autocar Professional

02:57 AM

Jul 22, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $529,500.00 in Stock - MarketBeat

Jul 22, 2025

Jul 22, 2025

Kennondale Capital Management LLC Has $571,000 Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 22, 2025

Jul 22, 2025

What analysts say about Akero Therapeutics Inc. stockFastest-growing stock picks - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Bank of New York Mellon Corp Purchases 12,235 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 22, 2025

Jul 21, 2025

Edgestream Partners L.P. Buys Shares of 6,947 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 21, 2025

Jul 20, 2025

Xponance Inc. Buys Shares of 5,565 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 20, 2025

Jul 18, 2025

257,025 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Purchased by Principal Financial Group Inc. - MarketBeat

Jul 18, 2025

Jul 17, 2025

Mirum Gains 35% in 3 Months: How Should You Play the Stock? - The Globe and Mail

Jul 17, 2025

Jul 16, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives $82.50 Average Price Target from Analysts - MarketBeat

Jul 16, 2025

Jul 16, 2025

Emerald Advisers LLC Has $11.92 Million Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 16, 2025

Jul 15, 2025

How Akero Therapeutics Inc. stock performs during market volatilityFree Stock Market Forecasting Tools - beatles.ru

Jul 15, 2025

Jul 15, 2025

Emerald Mutual Fund Advisers Trust Sells 145,145 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 15, 2025

Jul 14, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) CEO Andrew Cheng Sells 30,000 Shares - MarketBeat

Jul 14, 2025

Jul 14, 2025

Learn to Evaluate (AKRO) using the Charts - news.stocktradersdaily.com

Jul 14, 2025

Jul 13, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $638,625.00 in Stock - MarketBeat

Jul 13, 2025

Jul 11, 2025

Akero Therapeutics CEO Cheng sells $1.5m in stock By Investing.com - Investing.com Canada

Jul 11, 2025

Jul 06, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) VP Patrick Lamy Sells 2,000 Shares - MarketBeat

Jul 06, 2025

Jul 03, 2025

(AKRO) Investment Report - news.stocktradersdaily.com

Jul 03, 2025

Jul 03, 2025

Oppenheimer & Co. Inc. Invests $297,000 in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 03, 2025

Jun 30, 2025

Akero Therapeutics, Inc.(NasdaqGS: AKRO) dropped from Russell 3000 Value Index - MarketScreener

Jun 30, 2025

Jun 23, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Akero Therapeutics, Inc. (AKRO) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Jun 23, 2025

Jun 23, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) CTO Scott A. Gangloff Sells 848 Shares - MarketBeat

Jun 23, 2025

Jun 22, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives $82.50 Consensus Price Target from Analysts - MarketBeat

Jun 22, 2025

Jun 20, 2025

Akero therapeutics (AKRO) SVP Lamy sells $108k in stock By Investing.com - Investing.com UK

Jun 20, 2025

Jun 18, 2025

Akero Therapeutics (NASDAQ:AKRO) Stock Price Down 3.3%Time to Sell? - MarketBeat

Jun 18, 2025

Jun 15, 2025

Don't Ignore The Insider Selling In Akero Therapeutics - simplywall.st

Jun 15, 2025

Jun 15, 2025

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells 2,803 Shares of Stock - MarketBeat

Jun 15, 2025

Jun 14, 2025

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) COO Sells 2,493 Shares of Stock - MarketBeat

Jun 14, 2025

Jun 14, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $127,332.00 in Stock - MarketBeat

Jun 14, 2025

Jun 14, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) CFO Sells $151,387.96 in Stock - MarketBeat

Jun 14, 2025

Jun 14, 2025

Rhumbline Advisers Purchases 5,001 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jun 14, 2025

Jun 14, 2025

Millennium Management LLC Lowers Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jun 14, 2025